THE ROLE OF FERRITIN AS A RESPONSE MARKER FOR ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A (PEGIFN) AND RIBAVIRIN (RBV)

被引：0

作者：

Klass, Dietmar M. ^{[1
]}

Zizer, Eugen ^{[1
]}

Link, Ralph ^{[2
]}

Heyne, Renate ^{[3
]}

Lutz, Thomas ^{[4
]}

Schmidt, Wolfgang ^{[5
]}

Goesseringer, Roger ^{[6
]}

Alshuth, Ulrich ^{[6
]}

Mauss, Stefan ^{[8
]}

Hueppe, Dietrich ^{[7
]}

机构：

[1] Univ Hosp Ulm, Dept Internal Med 1, Ulm, Germany

[2] Ortenau Clin, Offenburg, Germany

[3] Gastroenterol & Liver Ctr, Berlin, Germany

[4] Infektiologikum, Frankfurt, Germany

[5] Ctr Gastroenterol, Berlin, Germany

[6] Roche Pharma AG, Grenzach Wyhlen, Germany

[7] Ctr Gastroenterol, Herne, Germany

[8] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：868A / 868A

页数：1

共 50 条

[1] SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV
Sulkowski, M.
Bourliere, M.
Bronowicki, J. -P.
Streinu-Cercel, A.
Preotescu, L.
Asselah, T.
Pawlotsky, J. -M.
Shafran, S.
Pol, S.
Caruntu, F. A.
Mauss, S.
Larrey, D.
Haefner, C.
Datsenko, Y.
Stern, J.
Kubiak, R.
Steinmann, G.
[J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S462 - S463
[2] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
Rakov, NE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
[3] Early prediction of response to 40 kDa peginterferon alfa-2a (PEGASYS®) plus ribavirin (RBV) in patients with chronic hepatitis C (CHC).
Ferenci, P
Shiffman, ML
Fried, MW
Sulkowski, MS
Haeussinger, D
Zarski, JP
Goncales, F
Jensen, DM
Bonino, F
Dhumeaux, D
Blotner, S
Hoffman, J
Oliveto, J
[J]. HEPATOLOGY, 2001, 34 (04) : 351A - 351A
[4] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C - Reply
Fried, MW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 260 - 260
[5] A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
Swain, Mark G.
Lai, Ming-Yang
Shiffman, Mitchell L.
Cooksley, W. Graham E.
Zeuzem, Stefan
Dieterich, Douglas T.
Abergel, Armand
Pessoa, Mario G.
Lin, Amy
Tietz, Andreas
Connell, Edward V.
Diago, Moises
[J]. GASTROENTEROLOGY, 2010, 139 (05) : 1593 - 1601
[6] Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Zeuzem, Stefan
[J]. JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 157 - 159
[7] Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment
Shiffman, ML
Di Bisceglie, AM
Lindsay, KL
Morishima, C
Wright, EC
Everson, GT
Lok, AS
Morgan, TR
Bonkovsky, HL
Lee, WM
Dienstag, JL
Ghany, MG
Goodman, ZD
Everhart, JE
[J]. GASTROENTEROLOGY, 2004, 126 (04) : 1015 - 1023
[8] Peginterferon alfa-2a in patients with chronic hepatitis C
Zeuzem, S
Feinman, SV
Rasenack, J
Heathcote, EJ
Lai, MY
Gane, E
O'Grady, J
Reichen, J
Diago, M
Lin, A
Hoffman, J
Brunda, MJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23): : 1666 - 1672
[9] The efficacy and influential factors of treatment with peginterferon alfa-2a and ribavirin in elderly patients with chronic hepatitis C
Yu, J. -W.
Sun, L. -J.
[J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S86 - S86
[10] Change of Treatment Patterns Over a Decade of Dual Therapy of Chronic Hepatitis C (CHC) With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)
Eisenbach, Christoph
Naumann, Uwe
Bokemeyer, Bernd
Pape, Stefan
Waizmann, Michael
Isernhagen, Konrad
Loehr, Hanns
Steffens, Hermann
Knechten, Heribert
Roessle, Martin
Haessner, Joachim
Racky, Stefan
Alshuth, Ulrich
Buggisch, Peter
Hueppe, Dietrich
[J]. GASTROENTEROLOGY, 2012, 142 (05) : S957 - S958

← 1 2 3 4 5 →